Cambridge Tech Podcast

James Parton & Faye Holland

Your weekly tech news download from in and around Cambridge, plus in-depth conversations with the founders, innovators, and enablers within the Cambridge tech ecosystem. Published every week and hosted by James Parton and Faye Holland. Get in touch with the show via info@cambridgetechpodcast.com Hosted on Acast. See acast.com/privacy for more information.

  1. How Concr is Revolutionising Cancer Treatment Prediction

    FEB 17

    How Concr is Revolutionising Cancer Treatment Prediction

    Episode 179 hosts Faye Holland and James Parton sit down with Irina Barbina (CEO) and Matthew Griffiths (CTO) to unpick how Concr is using predictive modelling and digital twins to transform cancer drug development. Cancer data is fragmented. Clinical trials, pre-clinical research, and real-world patient data exist in silos. There's no unified way to predict how individual patients will respond to specific therapies, until now. Concr's technology borrows from astrophysics, specifically, how scientists model dark matter using gravitational lensing. The parallel is striking: Astrophysicists can't directly observe dark matter, so they build complex simulations to infer its distribution. Concr can't directly know why a drug worked for a patient, so they build digital twin simulations to predict outcomes. Key innovations: ·      Bayesian inference at scale to handle messy, incomplete cancer data ·      Hierarchical modelling that learns from shared biology across cancer types ·      94% prediction accuracy on retrospective clinical trial data ·      Prospective validation underway with NHS partners and pharma companies Concr dramatically reduces the cost and complexity of clinical trials. This episode brilliantly illustrates why Cambridge is a global innovation hub. It's not just about brilliant science, it's about brilliant people from different disciplines colliding, recognising patterns, and building companies that matter. Hosted on Acast. See acast.com/privacy for more information.

    32 min
  2. Young People and the Future of Work in the Age of AI, with Form the Future

    FEB 10

    Young People and the Future of Work in the Age of AI, with Form the Future

    The latest Cambridge Tech Podcast episode tackles one of the most pressing challenges facing the tech industry today: how do we prepare the next generation for a world fundamentally reshaped by artificial intelligence? The Problem Is Real The statistics are sobering. The UK has 700,000 unemployed graduates struggling to gain a foothold in the labour market. Young people aren't just worried about AI - they're confused and increasingly anxious about their futures. What makes this episode essential listening is the nuanced, multi-stakeholder perspective it brings, including Liz Tolcher, Associate Partner, PA Consulting; Ayeisha Kone-Massouma, Degree Apprentice Project Manager, Bidwells; and those noted below. The podcast brings together educators, employers, policymakers, and AI experts to explore three critical themes: 1. Self-Knowledge Over Specialisation Anne Bailey, CEO & Co-Founder, Form the Future emphasises that young people's greatest asset is self-awareness: "Your uniqueness, your humanity, your curiosity, your interest, your values - these are the things that should be the driving factors in thinking about what work you want to do in the future." 2. Foundational Skills Matter Most Agnieszka Iwasiewicz-Wabnig FRSA, Director, Maxwell Centre, University of Cambridge, argues that critical thinking, ethical discernment, and mental agility are non-negotiable: "Invest in foundational skills, invest in exercising your mental capabilities and you will be competitive against any AI." Aga also raises an important tension: over-optimisation for productivity might actually stifle innovation. Without room for experimentation, there's no space for human creativity to thrive. 3. Responsible AI Development for Children Maria Luciana Axente, Founder & CEO, Responsible Intelligence, highlights that most technology isn't built with young people in mind. The UK's "age-appropriate design" legislation represents a breakthrough, but urgent action is needed to prioritise children in AI policy and design. Tune in on your chosen podcast platform to subscribe and listen. Headline sponsor Holden Polestar Hosted on Acast. See acast.com/privacy for more information.

    38 min
  3. Revolutionising Sustainable Medicine Discovery with How HotHouse Therapeutics

    JAN 13

    Revolutionising Sustainable Medicine Discovery with How HotHouse Therapeutics

    Episode 174 of the Cambridge Tech Podcast reveals an extraordinary approach to drug discovery that sounds like science fiction but is very much reality. If you've ever wondered how we might make pharmaceutical manufacturing greener without sacrificing innovation, this week's episode delivers some genuinely exciting answers. HotHouse Therapeutics, a Norwich-based biotech spinout, is harnessing AI and plant biosynthesis to develop the next generation of therapeutic compounds - and they're doing it in greenhouses, not laboratories. Dr Dave Sheppard and D. Phil Spence joined the show to discuss their genuinely innovative approach to drug discovery. "We use AI and plants to make small molecule therapeutics. Plants have evolved these tools over millions of years to make small molecules - we essentially hijack this system and combine tools from different species to make new molecules with therapeutic purposes." We find out about: Compounds that would take synthetic chemists years to produce individuallyUsing greenhouses and vertical farming rather than chemical labsDiscovery projects (finding new compounds) and production projects (scaling hard-to-access natural compounds)HotHouse Therapeutics are not just building a company; they're pioneering an entirely new approach to drug discoveryOpening a funding round this month (January 2026), aimed expansion into additional therapeutic areas (neurodegeneration, oncology), and a continued focus on proving that sustainable drug discovery isn't just better for the planet, it's better for patients too. The team emphasises Norwich's emerging biotech ecosystem, particularly the John Innes Centre, Norwich Research Park, and Anglia Innovation Partnership. With eight team members currently and plans to scale to 20 post-funding, they're committed to keeping operations rooted in Norwich. This is genuinely exciting stuff. If you're interested in deep-tech innovation, sustainable biotech, or just want to hear how AI is enabling entirely new approaches to one of humanity's oldest challenges, this episode is essential listening. Hosted on Acast. See acast.com/privacy for more information.

    49 min

About

Your weekly tech news download from in and around Cambridge, plus in-depth conversations with the founders, innovators, and enablers within the Cambridge tech ecosystem. Published every week and hosted by James Parton and Faye Holland. Get in touch with the show via info@cambridgetechpodcast.com Hosted on Acast. See acast.com/privacy for more information.

You Might Also Like